Your search history is turned on.
Date: April 26, 2024 Jurisdictions: Alberta, British Columbia
1 CANAM BIOTECH INC. Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Patrick Brown, Chief Financial Officer of CanAm Biotech Inc. certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of CanAm Biotech Inc. (the issuer) for the interim period e...
1 CANAM BIOTECH INC. Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, J. Scott Munro, Chief Executive Officer of CanAm Biotech Inc. certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of CanAm Biotech Inc. (the issuer) for the interim period ...
Management's Discussion and Analysis CANAM BIOTECH INC. MANAGEMENTS DISCUSSION AND ANALYSIS OF THE COMPANYS FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE INTERIM PERIOD ENDED FEBRUARY 29, 2024 (Q1) FORM 51-102F1 DATE AND SUBJECT OF REPORT The following Management Discussion & Analysis (MD&A) is intended to assist in the ...
FORM 61 CANAM BIOTECH INC. INTERIM FINANCIAL STATEMENTS (Unaudited) For the three months ended February 29, 2024 (Q1) (Expressed in Canadian dollars) 2 CANAM BIOTECH INC. Index to Consolidated Financial Statements (Unaudited) As at February 29, 2024 Page ...
Date: March 18, 2024 Jurisdictions: Alberta
Create participation fee form FORM 13-501F2 CLASS 2 REPORTING ISSUERS PARTICIPATION FEE MANAGEMENT CERTIFICATION I, MUNRO, J. Scott, an officer of the reporting issuer noted below have examined this Form 13-501F2 (t he Form) being submitted hereunder to the Alberta Securities Commission and certify that to my knowle dge, having exercised reasonable diligence, the...
Date: March 18, 2024 Jurisdictions: Alberta, British Columbia
1 This is an unofficial consolidation of Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate reflecting amendments made effective January 1, 2011 in connection with Canadas changeover to IFRS. The amendments apply for financial periods relating to financial years beginning on or after January 1, 2011. This document is for reference purposes o...
Management's Discussion and Analysis CANAM BIOTECH INC. MANAGEMENTS DISCUSSION AND ANALYSIS OF THE COMPANYS FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE YEAR ENDED NOVEMBER 30, 2023 FORM 51-102F1 DATE AND SUBJECT OF REPORT The following Management Discussion & Analysis (MD&A) is intended to assist in the understanding of ...
FORM 61 CANAM BIOTECH INC. Consolidated Financial Statements (Audited) For the Year Ended November 30, 2023 (Expressed in Canadian dollars) Page 2 of 19 CANAM BIOTECH INC. Index to Consolidated Financial Statements As at November 30, 2023 Page INDEPENDENT AUDITORS REPOR...
Date: October 31, 2023 Jurisdictions: Alberta, British Columbia